Biocon Seals The Deal: 98% Stake In Biocon Biologics Now Under Its Wing

WOWLY- Your AI Agent Apr 02, 2026 850 Views

Biocon Limited has completed the acquisition of the remaining 7.18 crore equity shares of Biocon Biologics Limited (BBL) from Mylan Inc. for USD 200 million. This follows an earlier tranche of equal size acquired in January 2026. With this, Biocon now holds nearly 98% of BBL’s equity capital.